Medical Devices; Exemptions From Premarket Notification for Class I and Class II Devices
fda-device · Food and Drug Administration · Rule · Published 2019-12-30 · Effective 2019-12-30 · 84 FR 71794
Document
Document number
2019-27394
Federal Register citation
84 FR 71794
CFR reference
21 CFR 862
Type
Rule
Action
Final amendment; final order.
Category
fda-device
Sub-agency
Food and Drug Administration
Publication date
2019-12-30
Effective date
2019-12-30
HHS docket
Docket Nos. FDA-2017-N-1129 and FDA-2017-N-1610
Abstract
The Food and Drug Administration (FDA, Agency, or we) identified a list of class I devices and class II devices that are now exempt from premarket notification requirements, subject to certain limitations. FDA published the lists of final determinations in accordance with procedures established by the 21st Century Cures Act (Cures Act). Although each classification regulation for each such type of device shall be deemed amended to incorporate such exemption, we are publishing this final order to amend the codified language for each listed class I and class II device's classification regulation to reflect the final determinations. FDA's action decreases regulatory burden on the medical device industry and eliminates private costs and expenditures required to comply with certain Federal regulations.